VEGF bispecifics. | Merck and BioNTech are buying Chinese biotechs to gain PD-(L)1/VEGF bispecifics. AstraZeneca's CEO argued ...
Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. The firm said the main sentiment driver for Merck is ...
The U.S. Food and Drug Administration approved the Keytruda combination in malignant pleural mesothelioma in September. Keytruda, a cancer drug that harnesses a patient's immune system to fight tumors ...
Q3 2024 Earnings Conference Call November 14, 2024 8:00 AM ETCompany ParticipantsConstantin Fest - Head of Investor ...
Wolfe Research initiated coverage of Merck (MRK) with a Peer Perform rating. Published first on TheFly – the ultimate source for ...
Discover expert reviews on businesses and services that accept crypto. Easily browse, compare, and select the best options with just a few clicks ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback